Treatment Options For Vasculitis

Clinical Trials

Clinical trials are available for those who have vasculitis. These might be considered when patients are not responding well enough to the treatment options already available. One study is looking at creating a way to automatically be able to read a patient’s anti-neutrophil cytoplastic autoantibodies. Since these autoantibodies are critical for diagnosing and monitoring this condition, this research is hoping to be able to discover a way to allow for better disease management.

Another study is exploring the efficacy of low-dose naltrexone for vasculitis patients. Research for other conditions show this drug may be beneficial for pain, so the hope is it may also help to alleviate specific physical symptoms of vasculitis. A third trial is targeted at patients experiencing vasculitis and polymyalgia rheumatica. This research is looking at sarilumab, a type of drug, to determine if it might reduce flares and improve remission rates.